Denis Dufrane
Directeur Général chez Novadip Biosciences SA
Profil
Denis Dufrane is the founder of Novadip Biosciences SA, a company founded in 2013, where he holds the title of Chief Executive & Scientific Officer, Director.
He is currently a Member at Superior Health Council.
In the past, Mr. Dufrane worked as the Medical Director-Endocrine Cell Therapy Unit at Cliniques Universitaires Saint-Luc from 2002 to 2015.
Postes actifs de Denis Dufrane
| Sociétés | Poste | Début |
|---|---|---|
Novadip Biosciences SA
 Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Directeur Général | 01/01/2013 |
| Superior Health Council | Corporate Officer/Principal | - |
Anciens postes connus de Denis Dufrane
| Sociétés | Poste | Fin |
|---|---|---|
Cliniques Universitaires Saint-Luc
 Cliniques Universitaires Saint-Luc Hospital/Nursing ManagementHealth Services Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium. | Corporate Officer/Principal | 01/08/2015 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Novadip Biosciences SA
Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Health Technology |
Cliniques Universitaires Saint-Luc
Cliniques Universitaires Saint-Luc Hospital/Nursing ManagementHealth Services Cliniques Universitaires Saint-Luc operates as a hospital which provides reference care and treats serious, rare or complex diseases of patients. The company was founded on August 23, 1976 and is headquartered in Brussels, Belgium. | Health Services |
| Superior Health Council |